{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:42:18Z","timestamp":1771263738990,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Oxford University Clinical Research Unit"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Chromobacterium violaceum<\/jats:italic> is a rare but severe and often fatal cause of disease in humans. We present 2 clinical cases of sepsis and skin abscesses \/ cellulitis caused by <jats:italic>C. violaceum<\/jats:italic> seen in a referral hospital for infectious diseases in Vietnam. Both patients survived, but appropriate antibiotic treatment was only installed after culture of the organism. We reviewed and summarised the characteristics of <jats:italic>C. violaceum<\/jats:italic> infection and treatment.<\/jats:p>","DOI":"10.1186\/s12879-024-09390-1","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T10:01:47Z","timestamp":1716285707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical presentation\u00a0and treatment of 2\u00a0patients with\u00a0infection\u00a0caused by Chromobacterium violaceum\u00a0in Vietnam"],"prefix":"10.1186","volume":"24","author":[{"given":"B\u00f9i V\u0103n","family":"Nam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00f9i Thanh","family":"H\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0110\u1eb7ng Th\u1ecb","family":"Th\u00fay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Rogier","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00f9i V\u0169","family":"Huy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"9390_CR1","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s42770-021-00460-z","volume":"52","author":"MCdSR Mesquita","year":"2021","unstructured":"Mesquita MCdSR, Moreira JMAR, Nogueira BS, Morgado TO, Ribeiro M, Colodel EM, et al. Sepsis in cougar (Puma concolor) associated with Chromobacterium violaceum. Braz J Microbiol. 2021;52:1611\u20135.","journal-title":"Braz J Microbiol."},{"issue":"2","key":"9390_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3329\/akmmcj.v10i2.44131","volume":"10","author":"S Sharmin","year":"2019","unstructured":"Sharmin S, Kamal SMM. Review on Chromobacterium violaceum, a rare but fatal bacteria needs special clinical attention. Anwer Khan Mod Med Coll J. 2019;10(2):169\u201375.","journal-title":"Anwer Khan Mod Med Coll J"},{"key":"9390_CR3","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.2147\/IJGM.S272193","volume":"14","author":"B Alisjahbana","year":"2021","unstructured":"Alisjahbana B, Debora J, Susandi E, Darmawan G. Chromobacterium violaceum: a review of an unexpected scourge. Int J Gen Med. 2021;14:3259\u201370.","journal-title":"Int J Gen Med"},{"key":"9390_CR4","unstructured":"Steinberg JDL JP, Burd EM. Other gram-negative and gram-variable bacilli. In: Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 1600 John F. Kennedy Blvd: Elsevier; 2019;9:2847\u201364."},{"issue":"11","key":"9390_CR5","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1128\/JCM.01068-08","volume":"46","author":"S Baker","year":"2008","unstructured":"Baker S, Campbell JI, Stabler R, Nguyen HV, To DS, Nguyen DV, Farrar J. Fatal wound infection caused by Chromobacterium violaceum in Ho Chi Minh City Vietnam. J Clin Microbiol. 2008;46(11):3853\u20135.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"9390_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2334-13-4","volume":"13","author":"JI Campbell","year":"2013","unstructured":"Campbell JI, Lan NPH, Qui PT, Dung LT, Farrar JJ, Baker S. A successful antimicrobial regime for Chromobacterium violaceum induced bacteremia. BMC Infect Dis. 2013;13(1):4.","journal-title":"BMC Infect Dis"},{"key":"9390_CR7","unstructured":"Scott LW, Wendy JP. Septic shock in children: rapid recognition and initial resuscitation (first hour). 2023. Available from: https:\/\/www.uptodate.com\/contents\/septic-shock-in-children-rapid-recognition-and-initial-resuscitation-first-hour."},{"issue":"4","key":"9390_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","volume":"20","author":"RE Baker","year":"2022","unstructured":"Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL, et al. Infectious disease in an era of global change. Nat Rev Microbiol. 2022;20(4):193\u2013205.","journal-title":"Nat Rev Microbiol"},{"key":"9390_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40124-023-00286-3","volume":"11","author":"M Miranda","year":"2023","unstructured":"Miranda M, Nadel S. Pediatric sepsis: a summary of current defnitions and management recommendations. Curr Pediatr Rep. 2023;11:29\u201339.","journal-title":"Curr Pediatr Rep"},{"issue":"8","key":"9390_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11274-023-03636-x","volume":"39","author":"ML Carabal\u00ed-Isajar","year":"2023","unstructured":"Carabal\u00ed-Isajar ML, Rodr\u00edguez-Bejarano OH, Amado T, Patarroyo MA, Izquierdo MA, Lutz JR, Ocampo M. Clinical manifestations and immune response to tuberculosis. World J Microbiol Biotechnol. 2023;39(8):206.","journal-title":"World J Microbiol Biotechnol"},{"issue":"2","key":"9390_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/tropicalmed3020039","volume":"3","author":"TT Trinh","year":"2018","unstructured":"Trinh TT, Nguyen LDN, Nguyen TV, Tran CX, Le AV, Nguyen HV, et al. Melioidosis in Vietnam: recently improved recognition but still an uncertain disease burden after almost a century of reporting. Trop Med Infect Dis. 2018;3(2):39.","journal-title":"Trop Med Infect Dis."},{"key":"9390_CR12","first-page":"2706","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"BJ Currie","year":"2020","unstructured":"Currie BJ. Burkholderia pseudomallei and Burkholderia mallei: Melioidosis and Glanders. In: Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 1600 John F. Kennedy Blvd.: Elsevier; 2020. p. 2706\u201317."},{"key":"9390_CR13","doi-asserted-by":"publisher","first-page":"e005084","DOI":"10.1099\/jmmcr.0.005084","volume":"4","author":"Z Meher-Homji","year":"2017","unstructured":"Meher-Homji Z, Mangalore RP, D R Johnson P, Y L Chua K. Chromobacterium violaceum infection in chronic granulomatous disease: a case report and review of the literature. JMM Case Rep. 2017;4:e005084.","journal-title":"JMM Case Rep."},{"key":"9390_CR14","doi-asserted-by":"publisher","first-page":"w20220","DOI":"10.4414\/smw.2020.20220","volume":"150","author":"E Moretti","year":"2020","unstructured":"Moretti E, BaggiMenozzi F, Elzi L, Lepori M. Chromobacterium violaceum bacteraemia: a new entity in Switzerland. Swiss Med Wkly. 2020;150:w20220.","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"9390_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12879-021-06216-2","volume":"21","author":"L Lang","year":"2021","unstructured":"Lang L, Wang M, Huang X, Zhou H, Zhou Z, Huang L, et al. Successful treatment of a patient with recurrent infection of Chromobacterium violaceum. BMC Infect Dis. 2021;21(1):484.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09390-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09390-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09390-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T10:04:21Z","timestamp":1716285861000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09390-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9390"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09390-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"10 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An approval from the ethics committee was not necessary for the reason that all data was acquired through tests conducted for clinical purposes. The patient signed an institutional informed consent for receiving treatments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained from the patient\u2019s legal guardian(s) for the publication of this case report, and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"508"}}